Clinical Trial Update: A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the adequate dose and safety of DW-3102 in hypercholesterolemia patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• DW-3102

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia | Phase 2 | Status: UNKNOWN